 |
UK price cuts feature in finalised price scheme
Thursday 20 November 2008
The UK pharmaceutical industry has reached agreement with the government on a new pharmaceutical pricing scheme (PPRS) with both sides of the negotiations expressing satisfaction with the outcome. Price cuts are not to be as deep or rapid as first expected and pharmaceutical companies launching innovative medicines will have greater flexibility where pricing is concerned.
Latest News
US panel endorses non-inferiority studies for complicated skin infections
A US FDA advisory panel has overwhelmingly endorsed the use of non-inferiority studies for antibiotics to treat complicated skin and skin structure infections (cSSSI) but not for uncomplicated infections (uSSSI).
Thursday 20 November 2008
United Therapeutics' oral treprostinil fails Phase III PAH trial
United Therapeutics' oral treprostinil has failed its pivotal Phase III trial, FREEDOM-C, testing it as an adjunctive treatment in pulmonary arterial hypertension (PAH).
Thursday 20 November 2008
US's popularity as the market for first launch grows, Tufts finds
The number of new drugs that are marketed first in the US continues to climb, a recent analysis by Boston-based Tufts Center for the Study of Drug Development found.
Thursday 20 November 2008
Bernard Lemoine: strategic vision, concrete results
After 20 years as director-general of France's pharmaceutical industry association, Leem, Bernard Lemoine will step down at the end of January.
Thursday 20 November 2008
More News
Most Read
- Roche snaps up more biotech firms
- Omeros appoints David Mann to Board
- Yondelis to be filed for ovarian cancer after Phase III success
- Amgen's denosumab succeeds in key osteoporosis trial
- Elan and Wyeth's Alzheimer's hope fails to impress
- BMS makes $4.5 billion bid for ImClone Systems
- Xarelto gets EU CHMP nod
Features & Analysis
EU experts assess the role of biocides in antibiotic resistance
Could washing the dishes or applying make-up be contributing to the rise in antibiotic resistance? This is the worrying prospect raised by an advisory committee to the European Commission...
Ian Schofield - 14 November 2008
Infertility drugs: making miracle babies
There is a growing market for infertility drugs driven by the obesity epidemic and women delaying the age at which they choose to become pregnant, reports Dr Nicole Avena
Market Insight - 13 November 2008
UK private drug payments – a can of worms for the pharma industry
Last week Alan Johnson, the UK's health secretary, sparked controversy after announcing that National Health Service patients would be able to buy medicines privately without forfeiting their right to state-funded treatment.
Editorial - November 2008
EU backs aid for French personalised medicine project
Ian Schofield looks at a new French government-backed project that could lead to new ways of diagnosing and treating cancer and rare genetic diseases.
Commentary - November 2008
More Analysis
Blog
US post-election buzz: a tale of stem cells, trade agreements and power struggles
One week after US voters elected Illinois Democratic senator Barack Obama as their next president, we offer a few interesting post-election tidbits on which Scrip's Washington bureau is keeping an eye (and that don't involve use of a crystal ball or an Ouija board to divine the name of the next FDA commissioner).
Read More
Posted 11/11/2008 12:54:35 PM
by Sue Sutter,
Washington Editor
There's no ignoring a meta-analysis
Pharmaceutical companies should proceed with great care in deciding whether to conduct a meta-analysis, and the results should be used "ever so cautiously, if at all, in making decisions", a former industry exec believes.
Read More
Posted 27/10/2008 15:36:23 PM
by Sue Sutter,
Washington Editor
About Scrip
Scrip World Pharmaceutical News provides you with high quality news coverage of pharma and biotech and also gives you strategic data and analysis.
Benefits include:
›› Daily email headlines
›› Searchable news
archive
›› Weekly copies of Scrip
›› Bespoke Scrip supplements
›› Plus the Scrip Yearbook
and Scrip League Tables
Events
2nd Annual Vaccines Asia 2008
10 November 2008
Renaissance Beijing Capital Hotel,
China
AAPS Annual Meeting & Exposition
16 November 2008
Atlanta,
USA
Scrip Directory
Scrip Directory 2008
Search over 20,000 international contacts and access potential business opportunities
© Informa plc. All rights reserved. This site is owned and operated by Informa plc ("Informa") whose registered office is
Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36
